Danaher Corp. (NYSE: DHR – $89.14) a manufacturer of professional, medical, industrial and commercial products, reported financial results for the second period that topped analyst estimates. Net income for the quarter was $695.6 million up from $676.4 million in the second quarter of last year. On an adjusted basis, net income for the quarter was $1.08 per share, up from $1.03 per share in the prior year period and higher than the $1.04 per share Street consensus. Sales were $5.13 billion, up from $4.96 billion reported for the same period last year and higher than the $5.06 billion analyst had estimated. For the third quarter, Danaher expects adjusted earnings to range from $1 to $1.04 per share and for the full year 2015, the company envisions adjusted earnings guidance to range from $4.25 to $4.33, vs. Street consensus of $4.28. After penning a takeover deal for Pall Corp., Danaher has announced plans to split itself at some point next year. The two resulting businesses would be a science and technology company, which would include Pall and an industry company. The science business was slated to keep the Danaher name and include Danaher’s life sciences and diagnostics and dental segments, as well as its water quality and product-identification platforms. The remaining business lines will include the company’s commercial and industrial products. The stock is up nearly 16% over the past 52 weeks to a near all-time high of $90.25 set back in May. The shares can continue to be held.